Mayo Clinic creates genetic test to help guide diagnosis, tr
Mayo Clinic has created a genetic test to help guide diagnosis and treatment of patients with diffuse large B-cell lymphoma, the most common type of non-Hodgkin's lymphoma. The Lymph2Cx test helps determine where the lymphoma started, assigning "cell-of-origin" groups using a 20-gene expression-based assay. It is the first test to go into the Mayo practice from the new Mayo Clinic Molecular Diagnostic Arizona Laboratory. The lab enables Mayo physicians and researchers to access new and existing tests rapidly to improve patient care....

http://www.news-medical.net/news/20161216/Mayo-Clinic-creates-genetic-test-to-help-guide-diagnosis-treatment-of-lymphoma-patients.aspx
Like
Comment
Share